CMC Enterprise Pharmacy Recalls Magnesium Sulfate Bags Due to Sterility Concerns
CMC Enterprise Pharmacy is recalling 2,162 bags of Magnesium Sulfate 1 GM in NS 50 mL due to a lack of sterility assurance. The affected products were distributed in North Carolina.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the severity rubric, an FDA Class II recall involving a drug with a sterility defect (a significant injury risk) corresponds to a score of 4 (Severe).
Plain-English summary
CMC Enterprise Pharmacy is recalling 2,162 bags of Magnesium Sulfate 1 GM in NS 50 mL. The recall is being conducted because of a lack of sterility assurance for the product. The affected bags were manufactured by Enterprise Pharmacy in Charlotte, North Carolina.
The recall covers specific lots with expiration dates ranging from May 4, 2019, to August 31, 2019. The affected lots include EK051810, EK281808, EL101810, EL141807, EA081910, EA161908, EA301908, EB111907, and EC041907. The products were distributed in North Carolina.
The FDA has classified this recall as Class II, which means that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences. Consumers and healthcare providers should stop using the affected products and contact the recalling firm for further instructions.
The recalled product
- Product
- Magnesium Sulfate 1 GM in NS 50 mL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.
- Manufacturer
- CMC Enterprise Pharmacy
- Category
- Drug — IV Solution
- Hazard
- Affected units
- 2,162
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lots: EK051810 Exp. 5/4/2019
- EK281808 Exp. 5/27/2019
- EL101810 Exp. 6/8/2019
- EL141807 Exp. 6/12/2019
- EA081910 Exp. 7/7/2019
- EA161908 Exp. 7/15/2019
- EA301908 Exp. 7/29/2019
- EB111907 Exp. 8/10/2019
- EC041907 Exp. 8/31/2019
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 32 recalled by CMC Enterprise Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · CMC Enterprise Pharmacy
See all →- SevereCMC Enterprise Pharmacy Recalls CeFAZolin Due to Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Oxytocin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Vancomycin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereDiltiazem 250 mg IV Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls CefTRIAXone Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereMagnesium Sulfate Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- SevereMagnesium Sulfate Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SeverePharmakon Recalls Magnesium Sulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharmakon Recalls Magnesium Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereSCA Pharmaceuticals Recalls Magnesium Sulfate Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2017-08-02
- SevereWellness Pharmacy Recalls Magnesium Sulfate Vials Due to Sterility Concerns
FDA (Drugs) · 2013-09-18